Navigation Links
Device prevents potential errors in children's medications
Date:1/8/2008

ANN ARBOR, Mich.---A device designed to eliminate mistakes made while mixing compounds at a hospital pharmacy was 100 percent accurate in identifying the proper formulations of seven intravenous drugs.

Five potentially serious medication errors were averted over an 18-month period in a test at C.S. Mott Children's Hospital in the University of Michigan Health System by using the technology, said Jim Stevenson, associate dean of Clinical Sciences at the U-M College of Pharmacy. Stevenson also directs Pharmacy Services at the U-M Health System.

Stevenson said the hospital is the first in the world to use this device to test patient drugs compounded in the pharmacy. The U-M Health System already has many safeguards, such as bar coding, in place to avert mistakes.

"Errors in compounding these types of medications are rare. However, when they occur they can have a significant negative impact on patients and staff," Stevenson said. "We know from having this technology in place we've deterred five errors that might have happened. I really believe having technology like this needs to be the standard around the country."

The table-top device manufactured by ValiMed, a division of Tuscon, Ariz.,-based CDEX Inc., uses a technique called enhanced photoemission spectroscopy to determine if the compounds are correct. Light is shot into the drug compound, which excites molecules, and the energy emitted by the excited molecules is measured by a spectrometer. Each drug compound tested has its own so-called light fingerprint, which is compared to the fingerprint of the control compound. If they match, the drug is considered correct.

There are many potential safeguards that are being pursued to improve medication safety, Stevenson said. However, the primary safeguard for intravenous drugs compounded in hospital pharmacies today remains a visual check by the pharmacist. Using a technology like this helps prevent mistakes that can occur due to human error, he said.

"Our goal needs to be to have zero tolerance for errors," Stevenson said. "If we wanted to eliminate errors completely we knew we couldn't continue to rely completely on human visual checking. We needed to implement some sort of technological solution to overlay our human process for these drugs to be failsafe."

The hospital tested 40-50 samples daily, at strengths and at variations below and above the proper dosage amount. The process takes about a minute, so the technology was able to be integrated into the workflow of the pharmacy when used for select high risk products, the paper said. The paper, "Enhanced photoemission spectroscopy for verification of high-risk IV medications," appears in the Jan. 1 issue of the American Journal of Health System Pharmacy.

The device is now used at C.S. Mott and University Hospital, both in the U-M Health System. The next step, Stevenson said, is for the company to develop more signatures so that more drugs can be tested

The idea for the project started in 2004 when Stevenson learned that a colleague at the University of Utah was using a similar device to test narcotics being returned in their operating room. Stevenson contacted the company about developing applications to check intravenous drug compounds prepared in the pharmacy for accuracy.


'/>"/>

Contact: Laura Bailey
baileylm@umich.edu
734-647-1848
University of Michigan
Source:Eurekalert

Related biology news :

1. Device helps patients survive, regain function til transplant
2. Researchers developing device to predict proper light exposure for human health
3. IGERT fellows to design biodevices using flexible electronics
4. MIT aids creation of neural prosthetic devices
5. Atmospheric measuring device for understanding smog formation
6. EMD Serono launches easypod, new electronic growth hormone injection device
7. Better protection for biomedial devices could result from Rutgers-Camden research
8. Implanting embryonic cardiac cells prevents arrhythmias
9. Pittsburgh scientists identify human source of stem cells with potential to repair muscle
10. Neuronal conduction of excitation without action potentials based on ceramide production
11. To maximize biofuel potential, researchers look for sorghums sweet spot
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
(Date:3/18/2016)... LONDON , March 18, 2016 ... Established Suppliers of Biometrics, ICT, Manned & Unmanned Vehicles, Physical ... & security companies in the border security market and ... and Europe has led ... your companies improved success. --> defence & ...
(Date:3/14/2016)... March 14, 2016 http://www.apimages.com ... --> - Renvoi : image disponible via ... --> --> DERMALOG, le ... de nouveaux lecteurs d,empreintes digitales pour l,enregistrement des ... sera utilisé pour produire des cartes d,identité aux ...
Breaking Biology News(10 mins):
(Date:5/20/2016)... ... 20, 2016 , ... The leading Regenerative Veterinary Medicine Company, VetStem Biopharma ... treated over 100 of their own patients with the VetStem Cell Therapy. Each of ... care for their patients. , The veterinarians are Dr Ross Rich former owner ...
(Date:5/19/2016)... ... May 19, 2016 , ... Anton Paar USA, located ... foot office building is complete. The new structure adds a third office building to ... Paar USA purchased 2.4 acres of land, along with office space adjacent to ...
(Date:5/19/2016)... SAN DIEGO , May 19, 2016 /PRNewswire/ ... (OTCBB: RGBP), (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced ... at creating the first cord blood based cancer ... a provisional patent application, Regen described a generation ... activity was potentiated by gene silencing.  The product ...
(Date:5/18/2016)... YORK , May 18, 2016 ... but it does not mean that there are no opportunities ... Threshold Pharmaceuticals Inc. (NASDAQ: THLD ), Seattle Genetics ... CHMA ), and Ophthotech Corp. (NASDAQ: OPHT ... trading alerts at: http://www.activewallst.com/ ...
Breaking Biology Technology: